← Akso Health Group AHG
Market Price
$1.41
Market Cap
$1.11B
P/E Ratio
N/A
Revenue (FY 2026)
↓-6.4% YoY
$13.83M
3-Yr CAGR: 1.6%
Net Income
↑86.2% YoY
-$18.67M
Net Margin: -135.0%
Free Cash Flow
↓-18,527.4% YoY
-$188.46M
FCF Yield: -16.92%
EPS (Diluted)
$-0.16
Basic: $-0.03
Return on Equity
Efficiency
-10.3%
ROA: -9.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (AHG)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $22.9M | — | $9.3M | $8.6M | — | $0.20 | — | $8.2M | — | — |
| FY 2018 | $107.3M | +368.0% | $75.9M | $65.5M | +664.0% | $1.37 | +585.0% | $87.7M | $87.3M | — |
| FY 2019 | $82.6M | -23.0% | $75.2M | $5.5M | -91.6% | $0.10 | -92.7% | $-1.7M | $-2.7M | -103.1% |
| FY 2020 | $19.0M | -77.0% | $6.9M | $-71.2M | -1,386.9% | $-1.46 | -1,560.0% | $-55.9M | $-56.2M | -1,999.5% |
| FY 2021 | $1.8M | -90.8% | $1.2M | $-34.8M | +51.1% | $-0.71 | +51.4% | $10.1M | $9.9M | +117.5% |
| FY 2022 | $6.3M | +259.7% | $0.9M | $-16.9M | +51.6% | $-0.28 | +60.6% | $-8.6M | $-8.6M | -187.6% |
| FY 2023 | $13.2M | +108.9% | $1.3M | $-1.4M | +91.9% | $-0.02 | +92.9% | $-3.3M | $-3.3M | +62.3% |
| FY 2024 | $2.4M | -81.7% | $0.1M | $-9.5M | -595.5% | $-0.07 | -250.0% | $1.4M | $1.4M | +141.5% |
| FY 2025 | $14.8M | +512.1% | $-0.3M | $-135.0M | -1,327.0% | $-0.16 | -128.6% | $1.2M | $1.0M | -24.3% |
| FY 2026 | $13.8M | -6.4% | $-0.0M | $-18.7M | +86.2% | — | — | $-12.8M | $-188.5M | -18,527.4% |
Valuation
Market Price
$1.41
Market Cap
$1.11B
Enterprise Value
$1.11B
P/E Ratio
N/A
P/B Ratio
6.68
FCF Yield
-16.92%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
-0.08%
Operating Margin
-28.92%
Net Margin
-134.99%
Return on Equity (ROE)
-10.32%
Return on Assets (ROA)
-9.85%
Asset Turnover
0.07x
Revenue 3-Yr CAGR
1.61%
Financial Health & Liquidity
Current Ratio
4,767.97
Cash Ratio
66.50
Debt / Equity
0.000
Debt / Assets
0.000
Cash & Equivalents
$170.57K
Total Debt
$27.70K
Book Value / Share
$0.21
Cash Flow Efficiency
Operating Cash Flow
-$12.79M
Capital Expenditures (CapEx)
$175.67M
Free Cash Flow
-$188.46M
OCF / Revenue
-92.48%
FCF / Revenue
-1,362.48%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.16
EPS (Basic)
$-0.03
Dividends / Share
N/A
Book Value / Share
$0.21
EPS YoY Growth
N/A
Balance Sheet (FY 2026)
Total Assets
$189.63M
Total Liabilities
$8.71M
Stockholders' Equity
$180.92M
Current Assets
$12.23M
Current Liabilities
$2.56K